Has Jerry Wolinsky received payments from drug or device companies?

Yes. Drug and device makers reported $165,360 in general payments to Jerry Wolinsky across 138 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jerry Wolinsky did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jerry Wolinsky come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jerry Wolinsky

Neurology · Houston, TXNPI 1578599007

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (48.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by F. Hoffmann-la Roche AG at 32.8% of the total. Reporting peaked in 2019 at $131,596 and has fallen 99.7% since, to $345 in 2025. Among neurology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$165,360in general payments, 2019–2025

Across 138 payments — averaging $1198.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

F. Hoffmann-la Roche AG$54K
Novartis Pharma AG$41K
Sanofi-aventis U.S. LLC$19K
Genentech, Inc.$16K
EMD Serono, Inc.$13K
Greenwich Biosciences, Inc.$7K
plus $15K from 7 others

$103,950in research payments, 2019–2025

Across 71 payments — averaging $1464.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

F. Hoffmann-la Roche AG$82K
Novartis Pharma AG$16K
Genentech, Inc.$3K
EMD Serono, Inc.$2K
Sanofi-aventis U.S. LLC$1K
Sanofi$449

What the payments were for

Consulting fees$79,74548%
Speaking & faculty fees$43,66726%
Travel & lodging$40,54125%
Food & beverage$1,4071%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
F. Hoffmann-la Roche AG	55	$54,261
Novartis Pharma AG	27	$41,340
Sanofi-aventis U.S. LLC	8	$18,809
Genentech, Inc.	17	$15,872
EMD Serono, Inc.	10	$13,383
Greenwich Biosciences, Inc.	6	$6,806
GW Pharma Limited	5	$6,602
Hexal AG	2	$4,225
Roche Products Limited	2	$2,100
EMD Serono Research & Development Institute, Inc.	2	$1,720
Genentech USA, Inc.	1	$124
Novartis	2	$99
TG Therapeutics, Inc.	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$165,360 in reported general payments places this provider in the 95th percentile of 1,246 neurology providers in Texas.

See all neurology providers in Texas →

Other neurology in Houston

William OndoHouston$1.4M
Pankaj SatijaHouston$1.1M
Annette HowardHouston$826K
Randolph EvansHouston$493K
Leorah FreemanHouston$401K
Mazen DimachkieHouston$388K
Zsila SadighiHouston$361K
Joseph JankovicHouston$323K
Raja MehannaHouston$300K
Eddie PattonHouston$299K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →